NCT07468851
- Conditions
- High-Risk Non-Muscle-Invasive Bladder Cancer
- Locations
-
- Peking University First Hospital Beijing, China
- Nanjing Drum Tower Hospital Nanjing, China
Clinical trial condition
High-Risk Non-Muscle-Invasive Bladder Cancer
Explore clinical trials studying High-Risk Non-Muscle-Invasive Bladder Cancer. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
High-Risk Non-Muscle-Invasive Bladder Cancer trial results
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
NCT06567743
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, High-Risk Non-Muscle-Invasive Bladder Cancer, +9 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Arizona Urology Specialty Tucson, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Arkansas Urology Little Rock, Arkansas, United States
NCT03191578
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Germans Trias i Pujol Hospital Badalona, Barcelona, Spain